Atlas Trials

Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease

Clinical trial NCT02685683 · TERMINATED

Trial details

NCT number
NCT02685683
Sponsor
Celgene
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2016-04-04
Primary completion
2017-09-25
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.